Companies in the life science sector developing innovative solutions and technologies.
Explore 1,566 recently funded life science companies with verified founder contact information and fundraising data.
General Cybernetics is a company that offers technology driven products and services.
Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.
Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.
Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients.
Bluephage is a biotechnology company that develops microbiological water quality testing products.
Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.
PanTarg develops antibody-drug conjugates for pancreatic cancer and other solid tumors.
Sci2sci builds software to verify enterprise data and trace AI outputs.
Sci2sci builds software to verify enterprise data and trace AI outputs.
BrainChild Bio develops chimeric antigen receptor T-cell therapies engineered to treat tumors of the central nervous system.
Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.
Liberty Gold is an exploration-stage company that engages in the exploration, production, and development of gold and precious metals.
Living In Silico offers biotechnology products and services using computer-based simulations.
Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.
KuriBio builds a nanotechnology platform for therapeutic applications in oncology and beyond.
Systemic Bio creates bioprinted organs-on-chips for drug discovery and development.
Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.
Lixa develops revolutionary, scalable solutions for antimicrobial resistance (AMR) and the US$5T per annum biofilm problem.
MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
ArsenalBio is a programmable cell therapy company that offers CAR T-cell therapies for solid tumors.
TriptoBIO is a biotechnology research company developing a platform for producing natural plant compounds.
Flip Therapeutics develops in vivo immune cell reprogramming therapies for chronic autoimmune and inflammatory diseases.
Science4Beauty develops and sells conotoxin-based skincare products and provides biotechnology services.
The life science sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Life Science companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The life science sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 1,566 life science companies tracked in the VCBacked database.
Companies in the life science sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting life science companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked